Genmab A/S ADS Stock Performance
as on June 19, 2026 at 2:15 pm IST
Day's Low
Day's High
$25.00$25.73
1.07%
Downside
1.82%
Upside
52 Week's Low
52 Week's High
$20.23$35.4319.96%
Downside
40.21%
Upside
Genmab A/S ADS share price movements today
- Previous Close
- $25.39
- Open
- $25.70
- Volume
- 1.4M
- Day's Low - High
- $25.00 - $25.73
- 52 Week Low - High
- $20.23 - $35.43
Genmab A/S ADS Historical Returns
- 1 Month Return
- -1.6 %
- 3 Month Return
- -1.79 %
- 1 Year Return
- + 17.21 %
- 3 Year Return
- -34.82 %
- 5 Year Return
- -41.12 %
Genmab A/S ADS Stock Fundamentals & Key Indicators
Check Genmab A/S ADS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$15.6B
EPS (TTM)
1.0413
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.73%
PE Ratio (TTM)
19.38
Industry PE ratio
-4.0832
PEG Ratio
1.6799
EBITDA
1.3B
Revenue (TTM)
3.9B
Profit Margin
21.05%
Return On Equity TTM
14.96%
Genmab A/S ADS Stock Valuation
Track how Genmab A/S ADS P/E has moved over time to understand its valuation trends.
Genmab A/S ADS in the last 5 years
Lowest (10.37x)
June 30, 2025
Industry (-4.08x)
June 19, 2026
Today (19.38x)
June 19, 2026
Highest (64.13x)
September 30, 2021
Today’s Price to Earnings Ratio: 19.38x
Genmab A/S ADS vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genmab A/S ADS with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $15.6B | -41.12% | 19.38 | 21.05% | NA | |
| BUY | $37.7B | 57.21% | 71.21 | 12.55% | NA | |
| BUY | $116.5B | 140.42% | 27.22 | 35.51% | NA | |
| BUY | $63.7B | 13.39% | 14.85 | 29.65% | 0.58% |
Stock Returns calculator for Genmab A/S ADS Stock including INR - Dollar returns
The Genmab A/S ADS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Genmab A/S ADS investment value today
Current value as on today
₹1,27,289
Returns
₹27,289
(+27.29%)
Returns from Genmab A/S ADS Stock
₹17,208 (+17.21%)
Dollar Impact
₹10,082 (+10.08%)
Analyst Recommendation on Genmab A/S ADS Stock
Based on 31 analysts
61.29%
Buy
29.03%
Hold
9.68%
Sell
Based on 31 analysts, 61.29% of analysts recommend a 'BUY' rating for Genmab A/S ADS. Average target price of $36.82
Genmab A/S ADS Share Price Target
Get share price movements and forecasts by analysts on Genmab A/S ADS.
What analysts predicted
31.37%UPSIDE
Target Price
$36.82
Current Price
$25.27
Analyzed by
31 Analysts
Target
$36.82
Genmab A/S ADS target price $36.82, a slight upside of 31.37% compared to current price of $25.27. According to 31 analysts rating.
Indian Investors' Interest in Genmab A/S ADS Stock
Search interest for Genmab A/S ADS Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
Genmab A/S ADS Quarterly Profit & Loss
All numbers in Millions USD
Genmab A/S ADS Annual Profit & Loss
All numbers in Millions USD
Genmab A/S ADS Quarterly Cash Flow
All numbers in Millions USD
Genmab A/S ADS Annual Cash Flow
All numbers in Millions USD
Genmab A/S ADS News & Key Events
Today's Timeline - 07 May
Thu, 08:32 PM
-Genmab reports Q1 2026 revenue growth of 25% to $896 million, driven by higher product sales and royalties.
Thu, 08:36 PM
-Genmab's operating profit misses expectations at $180 million, below the anticipated $187 million.
Fri, 02:28 AM
-Genmab maintains 2026 guidance with 14% revenue growth outlook, driven by EPKINLY and royalty portfolio.
Insights on Genmab A/S ADS
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 30.90M → 53.19M (in $), with an average increase of 41.9% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Genmab A/S ADS has experienced a drawdown of -34.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 12.3%
- NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 0.3%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 1.05B → 899.31M (in $), with an average decrease of 14.7% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, GMAB stock has moved down by -7.1%
About Genmab A/S ADS
| Organisation | Genmab A/S ADS |
| Headquarters | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
| Industry | Biotechnology |
| CEO | Dr. Jan G.J. van de Winkel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Genmab A/S ADS
Name | Title |
|---|---|
Mr. Gregory David Emil Mueller | Executive VP, General Counsel & Chief Legal Officer |
Mr. Christopher Cozic | Executive VP & Chief People Officer |
Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
Mr. Anthony Pagano CPA | Executive VP & CFO |
Mr. Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director |
Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
Dr. Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director |
Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
FAQs
What is Genmab A/S ADS share price today?
Genmab A/S ADS share price today is $25.27 as on at the close of the market. Genmab A/S ADS share today touched a day high of $25.73 and a low of $25.
What is the 52 week high and 52 week low for Genmab A/S ADS share?
Genmab A/S ADS share touched a 52 week high of $35.43 on and a 52 week low of $20.23 on . Genmab A/S ADS stock price today i.e. is closed at $25.27,which is 28.68% down from its 52 week high and 24.94% up from its 52 week low.
What is Genmab A/S ADS's market capitalisation today?
Genmab A/S ADS market capitalisation is $0.02T as on .
How to invest in Genmab A/S ADS Stock (GMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Genmab A/S ADS on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genmab A/S ADS Shares that will get you 0.0594 shares as per Genmab A/S ADS share price of $25.27 per share as on June 19, 2026 at 8:45 am IST.
What is the minimum amount required to buy Genmab A/S ADS Stock (GMAB) from India?
Indian investors can start investing in Genmab A/S ADS (GMAB) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Genmab A/S ADS stock (as per the Rupee-Dollar exchange rate as on ).
Based on Genmab A/S ADS share’s latest price of $25.27 as on June 19, 2026 at 8:45 am IST, you will get 0.3957 shares of Genmab A/S ADS. Learn more about
fractional shares .
What are the returns that Genmab A/S ADS has given to Indian investors in the last 5 years?
Genmab A/S ADS stock has given -41.12% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?